\
&
Contact us
\
&
Contact us
Published on | 5 years ago
Programmes ERC RI MSCA FET ICT NMBP SPACE Risk Finance SME Instrument Health Food Energy Transport Climate/Environment Societies Security Widening SwafS JRC COST EIC Pilot Batteries Circular Industries Horizon 2020 H2020 L+FThe recent escalation of restrictions related to the COVID-19 outbreak may hamper applicants’ ability to prepare and finalise high-quality proposals. For this reason, for Horizon 2020 calls with original deadlines between now and 15 April, extensions will be applied. The precise new deadlines for each call and topic will be published on the call and topic pages on the Funding and Tenders Portal.
For the following two calls, no extension of deadline/cutoff date will apply:
In all cases, potential applicants are advised to prepare themselves as necessary, especially by establishing effective communication links for remote collaborative work, also anticipating possible further restrictions in the coming weeks.
Source: Funding and tender portal – FAQ
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
